SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease

ClinicalTrials.gov ID: NCT02544204

Public ClinicalTrials.gov record NCT02544204. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 7:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2B Randomized Double Blind Placebo Controlled Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Direct Intramuscular Injection as Adjunct to Revascularization of Infrapopliteal Lesions in Subjects With Advanced Peripheral Artery Disease and Tissue Loss

Study identification

NCT ID: NCT02544204
Recruitment status: Not listed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Juventas Therapeutics, Inc.; Industry
Enrollment: 120 participants

Conditions and interventions

Conditions

Peripheral Arterial Disease

Interventions

JVS-100 Biological
Placebo Biological

Biological

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 31, 2015
Primary completion: Aug 31, 2017
Completion: Oct 31, 2017
Last update posted: Nov 1, 2016

2015 – 2017

United States locations

U.S. sites: 24
U.S. states: 16
U.S. cities: 21

Facility	City	State	ZIP	Site status
Cardiovascular Associates of the Southeast	Birmingham	Alabama	—	Not yet recruiting
UC Davis	Davis	California	—	Recruiting
Cedars-Sinai Heart Institute	Los Angeles	California	—	Recruiting
MedStar Georgetown UH	Washington D.C.	District of Columbia	—	Not yet recruiting
Morton Plant Hosptial - Baycare	Clearwater	Florida	—	Recruiting
Mount Sinai Medical Center	Miami	Florida	—	Recruiting
St. Joseph's Hospital	Tampa	Florida	33614	Recruiting
Northwestern	Chicago	Illinois	—	Recruiting
RUMC	Chicago	Illinois	—	Recruiting
Cardiovascular Institute of the South	Houma	Louisiana	—	Recruiting
St. John Hospital and Medical Center	Detroit	Michigan	—	Recruiting
Mayo	Rochester	Minnesota	—	Recruiting
Cardiology Associates Research	Tupelo	Mississippi	—	Recruiting
St. Luke's Mid America Heart Institute	Kansas City	Missouri	—	Recruiting
Holy Name Medical Center	Teaneck	New Jersey	—	Recruiting
UNC	Chapel Hill	North Carolina	—	Recruiting
NC Heart and Vascular Research	Raleigh	North Carolina	—	Recruiting
Summa Health	Akron	Ohio	—	Recruiting
Cleveland Clinic	Cleveland	Ohio	—	Recruiting
Metro Health	Cleveland	Ohio	—	Recruiting
University Hospitals	Cleveland	Ohio	—	Recruiting
Lifespan Health System	Providence	Rhode Island	—	Recruiting
VCU	Richmond	Virginia	—	Recruiting
Medical College of Wisconsin	Milwauke	Wisconsin	—	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02544204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 1, 2016 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02544204 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →